CAD and primary effusion lymphoma: In the KSHV-positive primary effusion lymphoma (PEL) cell line BCBL-1, depletion of CAD by CRISPR/Cas9 near-abolished cell proliferation (Figs. S6I and 6L) in vitro, which can be partially rescued by the expression of RelA-DD (Fig. S6J).